Unknown

Dataset Information

0

Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland.


ABSTRACT: Echinocandins represent the first-line therapy of candidemia. Echinocandin resistance among Candida spp. is mainly due to acquired FKS mutations. In this study, we report the emergence of FKS-mutant Candida albicans/glabrata in Switzerland and provide the microbiological and clinical characteristics of 9 candidemic episodes. All patients were previously exposed to echinocandins (median 26 days; range 15-77). Five patients received initial echinocandin therapy with persistent candidemia in 4 of them. Overall mortality was 33%.

SUBMITTER: Coste AT 

PROVIDER: S-EPMC7518979 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland.

Coste A T AT   Kritikos A A   Li J J   Khanna N N   Goldenberger D D   Garzoni C C   Zehnder C C   Boggian K K   Neofytos D D   Riat A A   Bachmann D D   Sanglard D D   Lamoth F F  

Infection 20200713 5


Echinocandins represent the first-line therapy of candidemia. Echinocandin resistance among Candida spp. is mainly due to acquired FKS mutations. In this study, we report the emergence of FKS-mutant Candida albicans/glabrata in Switzerland and provide the microbiological and clinical characteristics of 9 candidemic episodes. All patients were previously exposed to echinocandins (median 26 days; range 15-77). Five patients received initial echinocandin therapy with persistent candidemia in 4 of t  ...[more]

Similar Datasets

| S-EPMC1538661 | biostudies-literature
| S-EPMC5155041 | biostudies-literature
| S-EPMC6395934 | biostudies-literature
| S-EPMC8809326 | biostudies-literature
| S-EPMC5971591 | biostudies-literature
| S-EPMC3067100 | biostudies-literature
| S-EPMC3355103 | biostudies-literature
| S-EPMC7449192 | biostudies-literature
| S-EPMC3983340 | biostudies-literature
| S-EPMC4814137 | biostudies-literature